ISSN: 2206-7418Nanotheranostics
- Current Issue
- Volume 7, 2023
- Volume 6, 2022
- Volume 5, 2021
- Volume 4, 2020
- Volume 3, 2019
- Volume 2, 2018
- Volume 1, 2017
- Archive
- Cover images
- Cover suggestion
- Index & coverage
- Special issues
International Journal of Biological Sciences
International Journal of Medical Sciences
Global reach, higher impact
Nanotheranostics, the sister journal of Theranostics, is a multidisciplinary and fully open access journal. Currently, the journal does not charge any publication or submission fees (Platinum open access). Nanotheranostics publishes innovative and original basic, translational and clinical research reflecting the fields of nanomedicine, nanoimaging, drug and gene delivery, nanoelectronic biosensors, and related areas.
Regular features include high quality research articles, reviews or mini-reviews, rapid communication of preliminary data on innovative research, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical studies or ethical issues of nanomedicine are also welcome. Timely reviews that provide updates on current applications and issues in nanomedicine and translational aspects of nanotheranostics and other topics are particularly welcome and will be given high priority.
Nanotheranostics employs a rigorous peer-review system, but also strives for rapid review turnaround times and is based on the same streamlined submission platform as Theranostics.
Recent Papers:
Review
Current status of Cancer Nanotheranostics: Emerging strategies for cancer management
Vivek P Chavda, Avinash Khadela, Yasha Shah, Humzah Postwala, Pankti Balar, Lalit Vora
Nanotheranostics 2023; 7(4): 368-379. doi:10.7150/ntno.82263
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Research Paper
Indocyanine Green-based Glow Nanoparticles Probe for Cancer Imaging
Neeraj Chauhan, Marco Cabrera, Pallabita Chowdhury, Prashanth K.B. Nagesh, Anupam Dhasmana, Pranav, Meena Jaggi, Subhash C. Chauhan, Murali M. Yallapu
Nanotheranostics 2023; 7(4): 353-367. doi:10.7150/ntno.78405
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Research Paper
Combination of precipitation and size exclusion chromatography as an effective method for exosome like extracellular vesicle isolation from pericardial fluids
Dhananjie Chandrasekera, Rishi Shah, Isabelle van Hout, Willow De Jonge, Richard Bunton, Dominic Parry, Philip Davis, Rajesh Katare
Nanotheranostics 2023; 7(4): 345-352. doi:10.7150/ntno.82939
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Review
Engineering molecular nanoprobes to target early atherosclerosis: Precise diagnostic tools and promising therapeutic carriers
Chunfang Zan, Jie An, Zhifang Wu, Sijin Li
Nanotheranostics 2023; 7(3): 327-344. doi:10.7150/ntno.82654
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Research Paper
Preclinical safety assessment of photoluminescent metal quantum clusters stabilized with autologous serum proteins for host specific theranostics
Kritika Sood, Pranjali Yadav, Manu Jamwal, Reena Das, Asifkhan Shanavas
Nanotheranostics 2023; 7(3): 316-326. doi:10.7150/ntno.82978
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Research Paper
Curcumin Nanofiber PCL/PLGA/Collagen Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cells against Liver Fibrosis in Animal Model and Prevented its Recurrence
Gehan Abd-Elfatah Tawfeek, Hend Ahmed Kasem, Sherif Elsayed Elshoala
Nanotheranostics 2023; 7(3): 299-315. doi:10.7150/ntno.81019
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Research Paper
In vivo Study of Chalcone Loaded Carbon Dots for Enhancement of Anticancer and Bioimaging Potencies
Mochamad Zakki Fahmi, Yu-Yu Aung, Musbahu Adam Ahmad, Alfinda Novi Kristanti, Satya Candra Wibawa Sakti, Oka Pradipta Arjasa, Hwei Voon Lee
Nanotheranostics 2023; 7(3): 281-298. doi:10.7150/ntno.80030
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Research Paper
Hybrid Inorganic Complexes as Cancer Therapeutic Agents: In-vitro Validation
Murlidhar A Betallu, Shaileshkumar R Bhalara, Kailash B Sapnar, Vijay B Tadke, Keerti Meena, Ananya Srivastava, Gopal C Kundu, Mahadeo Gorain
Nanotheranostics 2023; 7(3): 270-280. doi:10.7150/ntno.81557
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
| Editor-in-Chief: Jonathan Lovell, PhD Associate Professor, Biomedical Engineering University at Buffalo, State University of New York |
|
Nanotheranostics has been selected by The Literature Selection Technical Review Committee (LSTRC) for inclusion in MEDLINE, the prestigious index of U.S. National Library of Medicine. Nanotheranostics is now indexed in the Web of Science, Biological Abstracts and BIOSIS Previews.
Impact score is 5.28, and h-Index is 20 based on information from Resurchify 2022. |
| The most significant feature of translational point-of-care technology “Personalized biosensors” is that it can be done quickly and by clinical staff who are not trained in clinical laboratory sciences. Rapid test results can quickly give a doctor or other medical worker answers that can help them decide what to do or how to treat a patient. This is helpful almost everywhere, from the emergency room to a patient getting care at home. When a doctor meets a patient for the first time, during a flare-up of a known problem or when a new symptom shows up in a patient who is already being.... Indocyanine green (ICG) is one of the FDA-approved near infra-red fluorescent (NIRF) probes for cancer imaging and image-guided surgery in the clinical setting. However, the limitations of ICG include poor photostability, high concentration toxicity, short circulation time, and poor cancer cell specificity. To overcome these hurdles, we engineered a nanoconstruct composed of poly (vinyl pyrrolidone) (PVP)-indocyanine green that is cloaked self-assembled with tannic acid (termed as indocyanine green-based glow nanoparticles probe, ICG-Glow NPs) for the cancer cell/tissue-specific targeting. The.... Extracellular vesicles (EVs), such as exosomes, are nanovesicles that have received significant attention due to their ability to contain various molecular cargos. EVs found in biological fluids have been demonstrated to have therapeutic potential, including as biomarkers. Despite being extensively studied, a significant downfall in EV research is the lack of standardised protocol for its isolation from human biological fluids, where EVs usually exist at low densities. In this study, we tested two well-established EV isolation protocols, precipitation, and size exclusion chromatography (SEC), to.... Background: The objective of this study was to demonstrate that synchrotron K-edge subtraction tomography (SKES-CT) can simultaneously track therapeutic cells and their encapsulating carrier, in vivo, in a rat model of focal brain injury using a dual-contrast agent approach. The second objective was to determine if SKES-CT could be used as a reference method for spectral photon counting tomography (SPCCT). Methods: Phantoms containing different concentrations of gold and iodine nanoparticles (AuNPS/INPs) were imaged with SKES-CT and SPCCT to assess their performances. A pre-clinical study was performed.... |